Used in research to detect and quantify the Asialoglycoprotein Receptor 1 (ASGR1) in liver tissues, this polyclonal antibody is valuable in studying liver function and diseases such as hepatitis, cirrhosis, and hepatocellular carcinoma. It enables immunohistochemistry, Western blotting, and ELISA applications, supporting investigations into receptor expression and cellular localization. Due to ASGR1's role in glycoprotein metabolism and immune modulation, the antibody aids in exploring targeted drug delivery systems, particularly those involving liver-specific uptake. It is also employed in validating ASGR1 knockout models and assessing the efficiency of gene editing techniques.